Suppr超能文献

格林-巴利综合征两种不同能力结局测量的反应性。

Responsiveness of 2 Different Ability Outcome Measures in Guillain-Barré Syndrome.

机构信息

Neurology Clinic, Clinical Center Nis, Nis.

Neurology Clinic, Clinical Center of Serbia, Belgrade, Serbia.

出版信息

Neurologist. 2021 Nov 4;26(6):244-247. doi: 10.1097/NRL.0000000000000341.

Abstract

BACKGROUND

The most frequently used ability outcome measure in Guillain-Barré syndrome (GBS) is the GBS disability scale (GDS). Recently developed inflammatory Rasch-built overall disability (I-RODS) scale has been suggested to be used in inflammatory polyneuropathies. In the present study, we wanted to assess the comparative responsiveness of I-RODS and GDS in subjects who were diagnosed with GBS during a follow-up period of 6 months.

METHODS

Our prospective, multicentric study included 72 subjects. Patients were tested, using GDS and I-RODS, on day 14, day 28, month 3, and month 6 from the start of the symptoms. We defined improvement as a reduction for 1 or more points on GDS or improvement on I-RODS as defined by Draak (2014).

RESULTS

Between days 14 and 28 there was an improvement in 28% of patients as measured with GDS and only in 10% patients as measured with I-RODS. At month 3 compared with day 14, we noticed an improvement in GDS score in 90% of GBS patients and I-RODS score in 65%. At month 6 improvements were noticed in 94% of patients measured by GDS and 78% according to I-RODS.

CONCLUSION

Our findings support the use of GDS in an acute phase of GBS. I-RODS have their role mostly during a longer follow-up period when the majority of patients are ambulant and their other abilities besides walking are also of great importance.

摘要

背景

在吉兰-巴雷综合征(GBS)中,最常使用的能力结局测量方法是 GBS 残疾量表(GDS)。最近开发的炎症性 Rasch 构建总体残疾(I-RODS)量表已被建议用于炎症性多发性神经病。在本研究中,我们希望在 6 个月的随访期间评估 I-RODS 和 GDS 在诊断为 GBS 的患者中的比较反应能力。

方法

我们的前瞻性、多中心研究纳入了 72 名患者。患者在症状开始后的第 14、28、3 个月和 6 个月,分别使用 GDS 和 I-RODS 进行测试。我们将改善定义为 GDS 降低 1 分或 1 分以上,或根据 Draak(2014)定义的 I-RODS 改善。

结果

在第 14 天至第 28 天之间,28%的患者根据 GDS 改善,而仅 10%的患者根据 I-RODS 改善。与第 14 天相比,在第 3 个月时,我们注意到 90%的 GBS 患者的 GDS 评分改善,65%的患者的 I-RODS 评分改善。在第 6 个月时,94%的患者根据 GDS 评分改善,78%的患者根据 I-RODS 评分改善。

结论

我们的研究结果支持在 GBS 的急性期使用 GDS。I-RODS 在患者大多可以行走且除行走外的其他能力也非常重要的更长随访期间发挥作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验